{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. Within 6 months of enactment, the Director of NIH will identify 3 to 5 diseases or health conditions with annual prevention and treatment costs exceeding $5 billion collectively. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires a total annual expenditure of at least $5 billion on prevention and treatment activities for selected diseases. Research investment for these diseases is low compared to other conditions with similar funding, making prize competitions a suitable approach to achieve the Act's goals. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the Director of NIH to design prize competitions to encourage innovation in addressing specific diseases. Prizes will be awarded to competitors with promising innovations or progress during the competitions. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the NIH Director to organize competitions to promote innovation in disease treatment. Prizes will be given to competitors with promising innovations or the best solutions at the end of the competitions. The design of the competitions should be realistic and unbiased towards any particular type of innovation. The NIH Director must organize competitions to promote innovation in disease treatment. Competitors can participate regardless of their place of incorporation, business location, citizenship, or residency. The competitions aim to address areas lacking recent innovations and must consult with various experts and federal agency heads. The Director of NIH will award contracts for a simulation of prize competitions under the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014, in consultation with experts and agency heads. The Director of NIH will award contracts for a simulation of prize competitions under the Health Prizes Act, and make adjustments to the design based on the results. The Director of NIH will make adjustments to the design of prize competitions and submit a report to Congress. Private entities will implement prize competitions based on the designs developed, requiring competitors to demonstrate effectiveness over a maximum of 5 years. The Secretary and the Commissioner of Food and Drugs may provide guidance and access to testing facilities for qualified competitors. The Secretary and the Commissioner of Food and Drugs may assist qualified competitors in prize competitions by offering guidance and testing facilities. The Director of NIH will conduct a maximum of 5 prize competitions, with no more than 2 competitions per disease. The Director will also track the medical efficacy and impact on federal expenditures of innovations funded through the competitions. The Federal Government may not acquire intellectual property rights without consent from participants in prize competitions. They can negotiate licenses for the use of intellectual property developed in these competitions. A report on the impact of innovations on federal expenditures must be submitted to Congress annually for 4 years after the competitions. Authorization of Appropriations: $50,000,000 is authorized to be appropriated for carrying out this section. A minimum percentage for prizes is set, with not more than 30 percent for administration and not less than 70 percent awarded as prizes to competitors in the prize competition. The Public Health Service Act authorizes $50,000,000 for prize competitions, with at least 70 percent awarded as prizes to competitors. Prizes received under this act are excluded from gross income."
}